Cargando…
Prevalence, causes and impact of TP53-loss phenocopying events in human tumors
BACKGROUND: TP53 is a master tumor suppressor gene, mutated in approximately half of all human cancers. Given the many regulatory roles of the corresponding p53 protein, it is possible to infer loss of p53 activity – which may occur due to alterations in trans – from gene expression patterns. Severa...
Autores principales: | Fito-Lopez, Bruno, Salvadores, Marina, Alvarez, Miguel-Martin, Supek, Fran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127307/ https://www.ncbi.nlm.nih.gov/pubmed/37095494 http://dx.doi.org/10.1186/s12915-023-01595-1 |
Ejemplares similares
-
TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening
por: Álvarez, Miguel M., et al.
Publicado: (2022) -
Passenger mutations accurately classify human tumors
por: Salvadores, Marina, et al.
Publicado: (2019) -
Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns
por: Salvadores, Marina, et al.
Publicado: (2020) -
Mutational signatures are markers of drug sensitivity of cancer cells
por: Levatić, Jurica, et al.
Publicado: (2022) -
Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells
por: Biayna, Josep, et al.
Publicado: (2021)